643 participants
A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-10-28
- Start Date:
- 2011-09-30
- Completion:
- 2015-12-31
Conditions
- Non-Squamous Non-Small Cell Lung Cancer
Interventions
- DRUG